Immutep (IMMP) Stock Highlights

2.03 | -4.25%

2024-12-21 06:05:25

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its lead product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives most of the revenue from the sale of the products.

Statistics

Range Today

2.03 2.17

Volume Today 226.2K

Range 1 Year

1.66 3.34

Volume 1 Year 52.66M

Range 3 Year

1.47 3.9

Volume 3 Year 215.23M

Range 10 Year

0.53 21.6

Volume 10 Year 1.21B

Highlights

Market Capitalization 269.82M (small)

Floating Shares 1.27B

Current Price 2.03

Price To Earnings -8.41

Price To Revenue 654.45

Price To Book 14.27

Earnings Per Share -0.22

Payout Ratio 0%

Performance

Latest -4.25%

1 Month 0%

3 Months -10.57%

6 Months -19.44%

1 Year -15.77%

3 Years -39.22%

5 Years +20.83%

10 Years -28.35%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.